JP2019511201A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019511201A5 JP2019511201A5 JP2018537519A JP2018537519A JP2019511201A5 JP 2019511201 A5 JP2019511201 A5 JP 2019511201A5 JP 2018537519 A JP2018537519 A JP 2018537519A JP 2018537519 A JP2018537519 A JP 2018537519A JP 2019511201 A5 JP2019511201 A5 JP 2019511201A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- homology
- seq
- domain
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1600559.7A GB201600559D0 (en) | 2016-01-12 | 2016-01-12 | Therapeutic molecules |
| GB1600559.7 | 2016-01-12 | ||
| GB1605770.5 | 2016-04-04 | ||
| GB201605770 | 2016-04-04 | ||
| GB201605763 | 2016-04-04 | ||
| GB1605763.0 | 2016-04-04 | ||
| PCT/GB2017/050075 WO2017122018A1 (en) | 2016-01-12 | 2017-01-12 | Molecules that bind prostate specific membrane antigen (psma) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019511201A JP2019511201A (ja) | 2019-04-25 |
| JP2019511201A5 true JP2019511201A5 (enExample) | 2020-02-20 |
| JP7190901B2 JP7190901B2 (ja) | 2022-12-16 |
Family
ID=57838417
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018537519A Active JP7190901B2 (ja) | 2016-01-12 | 2017-01-12 | 前立腺特異的膜抗原（ｐｓｍａ）と結合する分子 |
| JP2018537533A Pending JP2019506155A (ja) | 2016-01-12 | 2017-01-12 | 治療分子 |
| JP2021211614A Active JP7450594B2 (ja) | 2016-01-12 | 2021-12-24 | 治療分子 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018537533A Pending JP2019506155A (ja) | 2016-01-12 | 2017-01-12 | 治療分子 |
| JP2021211614A Active JP7450594B2 (ja) | 2016-01-12 | 2021-12-24 | 治療分子 |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US11236174B2 (enExample) |
| EP (2) | EP3402824A1 (enExample) |
| JP (3) | JP7190901B2 (enExample) |
| CN (3) | CN108473589B (enExample) |
| WO (3) | WO2017122017A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11236174B2 (en) * | 2016-01-12 | 2022-02-01 | Crescendo Biologics Limited | Therapeutic molecules |
| GB201607968D0 (en) * | 2016-05-06 | 2016-06-22 | Crescendo Biolog Ltd | Chimeric antigen receptor |
| EP3565842A1 (en) | 2017-01-06 | 2019-11-13 | Crescendo Biologics Limited | Single domain antibodies to programmed cell death (pd-1) |
| GB201711068D0 (en) * | 2017-07-10 | 2017-08-23 | Crescendo Biologics Ltd | Therapeutic molecules binding PSMA |
| JP7312168B2 (ja) * | 2017-11-13 | 2023-07-20 | クレッシェンド、バイオロジックス、リミテッド | Ｃｄ１３７に結合するシングルドメイン抗体 |
| GB201802573D0 (en) | 2018-02-16 | 2018-04-04 | Crescendo Biologics Ltd | Therapeutic molecules that bind to LAG3 |
| GB201818460D0 (en) * | 2018-11-13 | 2018-12-26 | Crescendo Biologics Ltd | Single domain antibodies that bind human serum albumin |
| AU2020252556B2 (en) * | 2019-04-05 | 2026-02-05 | Teneobio, Inc. | Heavy chain antibodies binding to PSMA |
| KR102260478B1 (ko) * | 2019-08-19 | 2021-06-02 | 연세대학교 산학협력단 | 일나트륨 요소화물 결정 용해용 조성물 |
| CN111303288B (zh) * | 2020-03-04 | 2020-12-25 | 和铂医药(苏州)有限公司 | 一种分离的结合抗原psma的蛋白及其用途 |
| JP2023532807A (ja) | 2020-07-08 | 2023-07-31 | ラヴァ・セラピューティクス・エヌ・ヴイ | Ｐｓｍａ及びガンマ－デルタｔ細胞受容体に結合する抗体 |
| CN112480260B (zh) * | 2020-12-09 | 2022-03-08 | 福州迈新生物技术开发有限公司 | 抗psma蛋白单克隆抗体、细胞系及其制备方法和应用 |
| MX2023009874A (es) * | 2021-02-25 | 2023-08-30 | Teneobio Inc | Anticuerpos anti-psma y estructuras car-t. |
| EP4392454A4 (en) * | 2021-08-27 | 2025-10-15 | Janssen Biotech Inc | ANTI-PSMA ANTIBODIES AND THEIR USES |
| GB202205589D0 (en) | 2022-04-14 | 2022-06-01 | Crescendo Biologics Ltd | Mesothelin binders |
| WO2023199069A1 (en) | 2022-04-14 | 2023-10-19 | Crescendo Biologics Limited | Chimeric antigen receptor that binds mesothelin |
| GB202214528D0 (en) | 2022-10-03 | 2022-11-16 | Owlstone Med Ltd | A compound |
| CN116271081A (zh) * | 2023-04-04 | 2023-06-23 | 上海愿智生物技术有限公司 | 一种抗体偶联药物yc1605及其药物组合物和应用 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0115256D0 (en) | 2001-06-21 | 2001-08-15 | Babraham Inst | Mouse light chain locus |
| US20050215472A1 (en) | 2001-10-23 | 2005-09-29 | Psma Development Company, Llc | PSMA formulations and uses thereof |
| ES2559002T3 (es) | 2001-10-23 | 2016-02-10 | Psma Development Company, L.L.C. | Anticuerpos contra PSMA |
| GB2398784B (en) | 2003-02-26 | 2005-07-27 | Babraham Inst | Removal and modification of the immunoglobulin constant region gene cluster of a non-human mammal |
| GB0313132D0 (en) | 2003-06-06 | 2003-07-09 | Ich Productions Ltd | Peptide ligands |
| GB0316294D0 (en) | 2003-07-11 | 2003-08-13 | Polytherics Ltd | Conjugated biological molecules and their preparation |
| WO2006089230A2 (en) | 2005-02-18 | 2006-08-24 | Medarex, Inc. | Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| CA2616859C (en) * | 2005-08-03 | 2015-04-14 | Fraunhofer Usa, Inc. | Compositions and methods for production of immunoglobulins |
| ES2597849T3 (es) | 2007-10-09 | 2017-01-23 | Polytherics Limited | Proteínas y péptidos conjugados novedosos |
| US20100122358A1 (en) | 2008-06-06 | 2010-05-13 | Crescendo Biologics Limited | H-Chain-only antibodies |
| WO2013045916A1 (en) | 2011-09-26 | 2013-04-04 | Kymab Limited | Chimaeric surrogate light chains (slc) comprising human vpreb |
| MX2014010183A (es) | 2012-02-22 | 2015-03-20 | Univ Pennsylvania | Composiciones y metodos para generar una poblacion persistente de celulas t utiles para el tratamiento de cancer. |
| CN103087171B (zh) | 2012-12-24 | 2015-01-14 | 中国人民解放军第四军医大学 | 一种用于前列腺癌早期诊断和治疗的抗psma/fitc双特异性抗体及其制备方法 |
| WO2014141192A1 (en) | 2013-03-15 | 2014-09-18 | Erasmus University Medical Center | Generation of heavy chain-only antibodies |
| CN103333249A (zh) | 2013-06-14 | 2013-10-02 | 广州康合生物科技有限公司 | 一种抗前列腺特异性膜抗原（psma）的单克隆抗体及其应用 |
| JP2017513818A (ja) | 2014-03-15 | 2017-06-01 | ノバルティス アーゲー | キメラ抗原受容体を使用する癌の処置 |
| TWI701042B (zh) | 2014-03-19 | 2020-08-11 | 美商再生元醫藥公司 | 用於腫瘤治療之方法及抗體組成物 |
| AU2015301460B2 (en) | 2014-08-14 | 2021-04-08 | Novartis Ag | Treatment of cancer using GFR alpha-4 chimeric antigen receptor |
| US11547099B2 (en) | 2014-10-22 | 2023-01-10 | Crescendo Biologies Limited | Transgenic mice |
| WO2016063006A1 (en) | 2014-10-24 | 2016-04-28 | Polytherics Limited | Conjugates and conjugating reagents |
| CN105384825B (zh) | 2015-08-11 | 2018-06-01 | 南京传奇生物科技有限公司 | 一种基于单域抗体的双特异性嵌合抗原受体及其应用 |
| US11236174B2 (en) * | 2016-01-12 | 2022-02-01 | Crescendo Biologics Limited | Therapeutic molecules |
| CN105968204B (zh) | 2016-02-03 | 2020-01-21 | 中国人民解放军第三军医大学第一附属医院 | 一种抗前列腺特异性膜抗原的单域重链抗体 |
| CN105968203A (zh) | 2016-02-03 | 2016-09-28 | 南昌大学 | 一种抗前列腺特异性膜抗原胞外区的单域重链抗体 |
| CN105968205B (zh) | 2016-02-03 | 2019-04-26 | 中国人民解放军第三军医大学第三附属医院 | 一种抗前列腺特异性膜抗原的纳米抗体 |
| GB201607968D0 (en) | 2016-05-06 | 2016-06-22 | Crescendo Biolog Ltd | Chimeric antigen receptor |
| GB201711068D0 (en) | 2017-07-10 | 2017-08-23 | Crescendo Biologics Ltd | Therapeutic molecules binding PSMA |
| JP7312168B2 (ja) | 2017-11-13 | 2023-07-20 | クレッシェンド、バイオロジックス、リミテッド | Ｃｄ１３７に結合するシングルドメイン抗体 |
-
2017
- 2017-01-12 US US16/069,497 patent/US11236174B2/en not_active Expired - Fee Related
- 2017-01-12 WO PCT/GB2017/050074 patent/WO2017122017A1/en not_active Ceased
- 2017-01-12 EP EP17700734.1A patent/EP3402824A1/en not_active Withdrawn
- 2017-01-12 US US16/069,495 patent/US10975161B2/en active Active
- 2017-01-12 CN CN201780006227.9A patent/CN108473589B/zh not_active Expired - Fee Related
- 2017-01-12 EP EP17701006.3A patent/EP3402825A1/en not_active Withdrawn
- 2017-01-12 JP JP2018537519A patent/JP7190901B2/ja active Active
- 2017-01-12 CN CN202310315828.5A patent/CN116478293A/zh active Pending
- 2017-01-12 WO PCT/GB2017/050075 patent/WO2017122018A1/en not_active Ceased
- 2017-01-12 CN CN201780006538.5A patent/CN108473590B/zh not_active Expired - Fee Related
- 2017-01-12 JP JP2018537533A patent/JP2019506155A/ja active Pending
- 2017-01-12 WO PCT/GB2017/050076 patent/WO2017122019A1/en not_active Ceased
-
2021
- 2021-10-22 US US17/508,583 patent/US11746158B2/en active Active
- 2021-12-24 JP JP2021211614A patent/JP7450594B2/ja active Active
-
2023
- 2023-06-28 US US18/343,126 patent/US20230406954A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019511201A5 (enExample) | ||
| JP7209464B2 (ja) | ヒトインターロイキン－２に対する免疫刺激性モノクローナル抗体 | |
| JP2020530285A5 (enExample) | ||
| ES2773504T3 (es) | Nuevo polipéptido que tiene afinidad por PD-L1 | |
| CN110627906A (zh) | 抗pd-l1/4-1bb双特异性抗体及其用途 | |
| JP2021502810A5 (enExample) | ||
| JP2019506155A5 (enExample) | ||
| RU2014120536A (ru) | Белки специфического связывания и их применения | |
| CN113330034A (zh) | 针对B7-H3的IgV结构域的单克隆抗体及其用途 | |
| JP2014113150A5 (enExample) | ||
| JP2007526233A5 (enExample) | ||
| JP2005518789A5 (enExample) | ||
| JP2011525354A5 (enExample) | ||
| JP2012100677A5 (enExample) | ||
| JP2014515600A5 (enExample) | ||
| JP2023519440A (ja) | 多重特異性抗体構築のためのプラットフォーム | |
| JP2015520172A5 (enExample) | ||
| JP2019504615A5 (enExample) | ||
| JP2019505785A (ja) | 食道癌の検出および治療のための組成物および方法 | |
| CN113227148B (zh) | 抗gpc3抗体、其抗原结合片段及其医药用途 | |
| JP2025026839A5 (enExample) | ||
| JP2019502923A (ja) | 卵巣癌の検出および治療のための組成物および方法 | |
| WO2021197358A1 (zh) | 一种抗pd-l1和pd-l2抗体及其衍生物和用途 | |
| CN117327182A (zh) | Cldn18.2单域抗体探针的制备方法及应用 | |
| JP7828286B2 (ja) | 抗ｍｕｃ１－ｓｅａ抗体 |